Aurora kinase inhibitor MK-5108, Purity ≥98%

Cat. No.: X23-10-ZQ475

Aurora kinase inhibitor MK-5108, Purity ≥98%

Synonym: MK-5108; 1010085-13-8; VX-689; MK 5108; MK5108; MK-5108 (VX-689); VX689; Aurora kinase inhibitor

  • MDL: MFCD22124479
  • CAS Number: 1010085-13-8
  • Compound CID: 24748204
Product Size
5 mg; 10 mg; 25 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
MK-5108, soluble in DMSO and insoluble in ethanol and water, is an Aurora kinase inhibitor that disrupts cell division processes. It targets Aurora A.
Molecular Weight
461.9
Molecular Formula
C22H21ClFN3O3S
Targets
Aurora A: 0.064 nM
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 81 mg/mL (175.35 mM); Water: Insoluble; Ethanol: Insoluble
Identity
Confirmed by NMR/HPLC/MS.
Stability
The product is stable for three years when stored at the recommended temperature in lyophilized powder.
Applications
MK-5108 is useful in research analyzing the inhibition of Aurora A kinase in cancer therapeutics.
Storage
Store at -20ºC.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.